-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Zura Bio Provides Clinical Update on Phase 2 Study of Tibulizumab in Hidradenitis Suppurativa

Reuters·11/09/2026 12:06:55

Please log in to view news